INTRODUCTION
The plasma transport of vitamin B12 (B-12)1 has been reviewed (1) . Radioactive B-12 bound to one of the transport proteins, transcobalamin II (TC II), is cleared rapidly from plasma (2, 3) , carries B-12 from the ileum to tissues (2, 4) , and is necessary for life (5) . This in vivo function is supported by the promotion by TC II of B-12 uptake by human cells in suspension (4, 6) . The hepatic uptake of TC II-Bn has been studied by external counting in man (4) . Tan (7) showed murine TC II-B12 to be taken up by the liver and kidney of the mouse. Tissues vary widely in their B-12 content (8) and posThis work was presented in part to the Federation of American Societies for Experimental Biology, Chicago, Ill., 13 April 1971. Received for publication 16 February 1972 and in revised form 1 May 1972. 1Abbreviations used in this paper: B-12, vitamin By; IF, intrinsic factor; TC I, transcobalamin I; TC II, transcobalamin IL sibly distribution could be influenced by the reaction between TC II and its receptors in different tissues.
Transcobalamin I (TC I) is the dominant carrier of B-12 in plasma after it has been in the body for hours or days (1, 2) . The need for two transport proteins has never been explained. Radioactive B-12 bound to TC I is cleared slowly from plasma (2, 3) and is not well taken up by cells in suspension (4, 6) . Clinical experience demonstrates that B-12 can move from stores to other tissues but TC I seems to be an unlikely transport protein for this role. Transport between organs by TC II has not been studied.
The above questions were approached by injection of free B-12 and B-12 bound to canine transport proteins into isolated, perfused organs of the dog. This model was chosen because the dog has a B-12 transport protein chemically and functionally like that of human TC II (9) . It was considered vital that the proteins and organs come from the same species. METHODS Isolated canine kidney and liver were perfused by a modification of the technique of Dodds which has been shown previously to sustain protein synthesis (10 The erythrocyte binder, which bound 30 pg of the 100 pg added, seemed to have an inhibitory effect on renal uptake; it was half that of '7CoBI2 in serum. Uptake of the erythrocyte binder by the liver was equal to that of free 'CoB,2, but less than half that of '7CoB12 in serum. Preliminary analysis of the output of the kidney by gel filtration -indicated that the 5TCoBn existed bound to a substance with the elution volume of TC II. To evaluate this further, the liver was subjected to three sets of injections, Fig. 1 . Serum (TC II)-CoBn2 had an uptake of 67% (60 pg) and free 'CoBn2 of only 27% (27 pg). The final hepatic injection was the renal output collected for 2 min after injection of 'CoB12. It contained 20 pg 'CoB12 and produced an uptake of 67% (14 pg) in the liver, in agreement with the per cent uptake after the initial serum (TC II)-B12 injection. On analysis of this renal output by gel filtration, the 'CoBI1 was bound exclusively to a protein of a molecular size corresponding to that of TC II (1, 11) .
Additional studies were performed in which the perfusion fluid entering the liver flowed from the hepatic vein to the kidneys (Fig. 2) . Of 100 pg unbound 'CoB12 injected into the liver, this organ took up only 14 pg while the kidneys took up 10 pg and 9 pg from the liver output. When, in the same system, the 100 pg 'CoBn2 en- Before the detection and study of B-12 transport pronately to a pro-teins in plasma there were many attempts to show that d secondarily to intrinsic factor (IF) or a related substance functioned se correspond to in the circulation as well as in the gut. The usual models ectively (1, 11) . were slices or homogenates of rat liver. There were some studies of serum-bound B-12 in these systems (13) . Subsequently, Gullberg (14) showed that the component of a isolated organs porcine IF preparation active in the rat liver homogenate or the first time. system was an "R" binder and not IF. Since in none of ot promote B-12 the earlier work were the B-12 binding components of simple presence IF or serum separated, it cannot be determined which Possibly some were the active principles. Lcted from perfu-the "R" binder in human gastric juice (16) , the third binder in human serum (15) , and human TC II (15) .
This lack of specificity is in sharp contrast to systems used to study intrinsic factor (14, 16) and the plasma B-12 binders in vitro (4, 6) . Production of TC II by the kidney has not been shown before. Tan (7) studied TC II production postnephrectomy in the mouse and considered liver to be the only source. A recent report of synthesis posthepatectomy (17) , however, supports the present findings. Since TC II is the only plasma binder of its molecular size (1, 11) , identification by gel filtration is reasonable. The +120,000 mol wt binder coming from the liver requires further identification since several B-12 binders in the body are of that size (1).
